AstraZeneca cancels £450m vaccine plant in UK

UK pharma major AstraZeneca has scrapped its plans to invest £450 million in expanding ($559 million) to expand its vaccine plant in Speke, Liverpool, blaming a reduction in government support.
Several factors have influenced this decision including the timing and reduction of the final offer compared to the previous ...